Advances in Hematology and Oncology Research(AHOR)
ISSN: 2692-5516 | DOI: 10.33140/AHOR
Impact Factor: 1.2
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
NTRK Fusion as an Acquired Mechanism of Resistance to Selpercatinib in RET Positive Thyroid Cancer
Citation
Nikita Chintapally, Kenneth Burman and Irina Veytsman
Chintapally, N., Burman, K., Veytsman, I. (2024). NTRK Fusion as an Acquired Mechanism of Resistance to Selpercatinib in RET Positive Thyroid Cancer. Adv Hema Onco Res, 7(2), 01-04.